Cumulus and mural granulosa cells of the ovarian follicle surround and interact with the developing oocyte. These follicular cells reflect the oocyte's overall health and may indicate subsequent developmental competence of embryos. Biomarkers of granulosa cells associated with individual oocytes could potentially be used in assisted reproduction to indicate which embryos have the best chance of implanting in the uterus and completing gestation. In this review, we have performed a comprehensive assessment of the recent literature for human cumulus and mural granulosa cell mRNA biomarkers as they relate to pregnancy and live birth. A critical discussion of variables affecting granulosa gene expression profiles for in vitro fertilization patients, including patient demographics and ovarian stimulation regimens, is presented. Although studies with microarray data were evaluated, this synopsis focuses on expressed genes that have been validated by quantitative RT-PCR. Furthermore, we summarize the current published data that support or refute identified granulosa expressed genes as potential biomarkers of embryos that give rise to ongoing pregnancy and live birth. Finally, we review studies that offer predictive models for embryo selection for uterine transfer based on biomarkers that show differential gene expression.
Introduction
Even with improvements in assisted reproductive technologies (ART) over the past couple of decades, the success rates for procedures treating infertility and leading to live births is still less than optimal. European data from 2011, as reported by the European IVFMonitoring Consortium and the European Society of Human Reproduction and Embryology showed the non-donor embryo transfer (ET) pregnancy rate was 33% with the pregnancy rate per embryo thaw cycle being 21% (Kupka et al. 2016) . Recent national summary data from 2013, as reported by the Society for Assisted Reproductive Technology's website (www. sart.org, 2016) , indicate the live birth rate in the United States from in vitro fertilization (IVF) non-donor fresh embryo transfers in patients less than 35 years old was approximately 48%. The live birth rate for thawed embryos in similar conditions was about 44%. This suboptimal success rate could be a direct consequence of embryo selection based on morphology and cleavage rates. In fact, Munne and coworkers (2007) reported that most morphologically normal appearing embryos (based on shape, size, blastomere number and fragmentation) may be aneuploid. In an analysis of 6000 embryos produced from oocytes of women less than 35 years of age, approximately 56% of embryos exhibiting the best morphology and development rate were actually aneuploid (Munne et al. 2007) . Furthermore, morphologically good, aneuploid embryos increased to nearly 80% for the women age 41 and older. These data indicate the need for better methodologies to reduce selection of aneuploid embryos.
In a later study, Munne and coworkers (2009) suggested that the best way to select euploid embryos for uterine transfer was to use a combination of both morphological appearance and preimplantation genetic screening (PGS). For PGS, 3-10 cells are biopsied from the trophectoderm of a day 5 or day 6 blastocyst for chromosome analysis. This approach has been validated by several groups that have demonstrated increased ongoing pregnancy, implantation and delivery rates of nearly 20% with PGS-screened vs non-PGS-screened embryos (Schoolcraft et al. 2010 , Yang et al. 2012 .
Although PGS has been shown to increase positive IVF outcomes in several studies, it requires invasive manipulation which might in turn harm the embryo, potentially decreasing successful outcomes. This idea is supported by a recent report that reviewed PGS embryo data in the United States for 2011 and 2012 and showed that using PGS-screened embryos did not increase IVF success rates. In actuality, the success rate per uterine transfer was reduced from 46.2% to 39.3% when PGS was utilized (Kushnir et al. 2016) . The authors of this study concluded that PGS decreases the chance of live birth and that improvements previously reported with PGS in women aged older than 37 years were due to selection bias. This conflicting PGS data may indicate that other methods beyond genetic screening are needed to improve IVF pregnancy rates. Additionally, a reproducible method for embryo selection for uterine transfer that does not require manipulation of the embryo would be advantageous.
There are several non-invasive methods for embryo selection that have been used in conjunction with embryonic morphological appearance and development rate. Numerous studies have evaluated the characteristics of granulosa cells, which surround the oocyte, follicular fluid contents or the secretions of the embryos while in culture. Several non-invasive methods for embryo assessment have been reviewed elsewhere and include the study of epigenomics, which consists of bisulfite sequencing to analyze DNA methylation of the granulosa cells (Egea et al. 2014) ; proteomics, including electrophoresis, chromatography and mass spectrometry of follicular fluid or oocyte culture media (Nel-Themaat & Nagy 2011); metabolomics of spent human embryo culture media by gas chromatography, high pressure liquid chromatography or nuclear magnetic resonance (Uyar & Seli 2014) and time-lapse imaging of embryos (Kirkegaard et al. 2015) . This review will focus on the area of transcriptomics that provides a quantitative assessment of mRNA expression and will focus on granulosa cell mRNA biomarkers that have been investigated as potential predictors of successful pregnancy from IVF.
Early assessment of RNA transcripts in granulosa cells addressed small numbers of genes and techniques utilized were less quantifiable. Such reports included semi-quantitative analyses of reverse transcription polymerase chain reactions (RT-PCR) and northern blotting of a single or handful of expressed genes. The ability to analyze thousands of transcripts simultaneously was made possible with the availability gene microarrays. Furthermore, the application of quantitative RT-PCR (qRT-PCR) allowed more accurate quantification and validation of transcript changes. A single microarray can exhibit hundreds, if not thousands, of differential mRNA gene expression (DRGE) patterns. Most candidate genes examined by microarray data will be selected by an arbitrary fold-change of around 1.5-to 2-fold. It is important to validate mRNA fold-changes by qRT-PCR to determine the actual statistical significance of the chosen genes of interest as microarray can produce false-positive signals (Provenzano & Mocellin 2007) . It is also important to keep in mind that although mRNA levels may change, the expression of their corresponding proteins may not exhibit the same patterns.
Groundbreaking early microarray work, which evaluated the transcriptomes of human luteinized granulosa cells from IVF patients, showed differences in thousands of mRNA transcripts between women with normal and diminished ovarian reserve; however, changes were not validated through qRT-PCR thereby limiting data interpretation (Chin et al. 2002) . RNA-seq is a more recent method that can replace microarrays; in this technique, RNA is converted to cDNA, and then undergoes deep sequencing to identify transcripts. Currently, there are very little data in this subject area using RNA-seq.
For the purposes of this review, only published microarray and qRT-PCR studies of cumulus cell (CC) and mural granulosa cells (MGC) gene expression related to assisted reproductive outcomes will be included. Although this review will emphasize CC markers related to pregnancy and live birth, selected studies showing the impact of patient characteristics on embryo quality will also be included. We have chosen to include the details of patient numbers and diagnoses, stimulation type and numbers of samples to communicate the great variation that exists in study design, and which is pertinent to the interpretation of outcomes.
Follicular cumulus and mural granulosa cell differences
In the Graafian follicle, in addition to the oocyte, there are distinct somatic cell populations. The theca cells form the internal and external thecal layers reside outermost and are separated from the inner granulosa cells by a basement membrane. Two distinct granulosa cell populations exist in the mature follicle, the MGC and the CC. CC surrounds the oocyte during follicular maturation and ovulation and remains attached to the oocyte after oocyte retrieval during ART. Together, the oocyte and CC form the cumulus-oocyte complex (COC). MGC and CC not only share many similarities but also have individual transcriptional patterns consistent with their specialized relationship with the oocyte (Huang & Wells 2010) and differential responsiveness to pituitary gonadotropins (Khamsi & Roberge 2001) . Indeed, there is bi-directional communication between the oocyte and its cumulus cells (Huang & Wells 2010) . Both MGC and CC are under the influence of oocyte-secreted factors in the transforming growth factor beta (TGFB) superfamily (Gilchrist et al. 2008) . Oocyte-secreted factors influence KIT ligand expression by granulosa cells, promote granulosa cell proliferation, prevent CC apoptosis, inhibit CC luteinization and regulate CC metabolism.
Three studies utilizing microarrays have demonstrated that MGC and CC isolated from the follicles of women undergoing ART exhibit vastly diverse RNA expression patterns. Koks and coworkers (2010) found nearly 500 RNAs altered ≥2-fold in pooled CC compared to pooled floating GC, which are predominantly MGC. A study by Grondahl and coworkers (2012) more systematically analyzed paired CC and MGC taken from a single large pre-ovulatory follicle containing a mature oocyte from each patient thereby controlling for oocyte maturational differences and oocyte yield. When comparing CC to MGC, more than 1500 RNAs varied by ≥2-fold between the two cell types. A third study examined MGC and CC samples from mature oocytes (Burnik et al. 2015b ) and conducted a meta-analysis with the data generated from the previous two studies ( Koks et al. 2010 , Grondahl et al. 2012 . When genes with log 2 fold-change ≥2 were evaluated collectively, 3156 genes were differentially expressed. Several of these differences were confirmed by qRT-PCR. The gene expression differences among the studies could be influenced by pooling or not pooling cells of different oocyte maturational status, different samples sizes in the number of oocytes per patient used and number of individual patients, stimulation types between studies, freezing and handling of cells and varying infertility diagnoses. Regardless, these studies demonstrate that the different expression profiles of the MGC and CC populations should be considered when examining possible pregnancy and live birth biomarkers.
Variables affecting granulosa cell transcriptomic profiles of IVF patients
One of the main difficulties when evaluating microarray and qRT-PCR data in CC and MGC in relation to embryo quality and other reproductive endpoints is the heterogeneous population of patients. Among the potentially complicating factors are the large variability in patient characteristics and the multiple stimulation types used during IVF procedures. Patient characteristics influencing IVF outcome and gene expression include age, body mass index (BMI), diagnosis, stimulation type, hormonal levels during stimulation and oocyte yield (Adriaenssens et al. 2010) . To further complicate matters, uterine receptivity also influences the interpretation of transcriptomic data such that a non-receptive uterus will cause implantation failure regardless of the quality of the embryo transferred. This section will review variables that impact the transcriptional profile of granulosa cells obtained from IVF protocols.
In terms of heterogeneous patient populations, the mixture of multiple diagnoses and stimulation types will skew many analyses. Adriaenssens and coworkers (2010) showed that mRNA gene expression profiles are influenced by a patient's biological characteristics, type of stimulation used for the patient's IVF cycle and oocyte developmental features. Thirteen different patient characteristics and biological variables as well as embryo development were similar between 35 patients stimulated with gonadotropin-releasing hormone (GnRH) agonist with high-purity human menopausal gonadotropin (HP-hMG) and 28 patients were stimulated with GnRH agonist with recombinant follicle-stimulating hormone (rFSH). Syndecan 4 (SDC4), versican (VCAN), gremlin 1, DAN family BMP antagonist (GREM1), sprouty RTK signaling antagonist 4 (SPRY4) and ribosomal protein S6 kinase A2 (RPS6KA2) showed differential expression based on the type of stimulation. Interestingly, SDC4, GREM1, SPRY4 and RPS6KA2 are all involved in TGFB or epidermal growth factor (EGF) signaling pathways.
The impact of different gonadotropin treatments on gene expression profiles of MGC and CC has been demonstrated by other groups as well. Grondahl and coworkers (2009) were the first to report DRGE profiles by microarray in MGC with GnRH agonist protocols using either rFSH or HP-hMG. Differential expression of 85 genes occurred including luteinizing hormone/choriogonadotropin receptor (LHCGR) and those involved in cholesterol and steroid synthesis, which had lower expression in the HP-hMG group compared to the rFSH group. Differential gene expression between HP-hMG and rFSH treatments in MGC was also corroborated in a subsequent study with 1736 genes exhibiting a ≥2-fold expression difference (Brannian et al. 2010) . Gatta and coworkers (2013) compared rFSH plus recombinant luteinizing hormone (rLH) or HP-hMG stimulation and found DRGE in CC by stimulus type. Two main clusters of genes varied with stimulation type by at least 1.7-fold with 61 genes being upregulated with HP-hMG and downregulated by rFSH plus rLH and 84 genes being upregulated with rFSH plus rLH and downregulated with HP-hMG compared to rFSH alone. The genes identified mediated functions related to retinoic acid transport, phosphatase enzymes, DNA methylation and transcription and oocyte/follicle development. Furthermore, Assou and coworkers (2013) retrospectively examined individual CC mass transcripts by microchip and embryo development using GnRH antagonist protocols with either HP-hMG or rFSH. In the HP-hMG group, 45 genes were significantly upregulated including those related to cell-cell interaction and lipid metabolism, whereas 49 genes were significantly upregulated in the rFSH group including extracellular matrix assembly and tumor necrosis factor family members. The above studies consistently used human chorionic gonadotropin (hCG) as a 'trigger' for final oocyte maturation prior to retrieval.
Not only does the type of GnRH-mediated stimulation alter the gene expression profiles of CC and MGC but also the 'trigger' medication does as well. After GnRH antagonist priming, hCG and GnRH agonist 'triggers' exhibited a ≥1.5-fold difference in genes expressed related to steroidogenic pathways in CC and angiogenic pathways in the MGC (Borgbo et al. 2013) . The GnRH agonist showed higher LHCGR mRNA in CC than the hCG. The 'trigger' dose of hCG has also been evaluated in
www.reproduction-online.org patients (Coskun et al. 2013) . The gene expression profiles between the groups receiving hCG (5000 or 10,000 IU) and the non-hCG group showed approximately 2000 genes up or downregulated by >1.5-fold in each hCG group; yet, only 15 genes differed significantly between 5000 or 10,000 IU of hCG. A GnRH 'trigger' leads to an endogenous increase in LH, whereas hCG serves to mimic the LH surge. hCG has a longer half-life and higher affinity than LH for the LH receptor (Choi & Smitz 2014 ); yet, LH is more potent at activating downstream signaling pathways. These findings suggest that possible differences in the activation of the LH receptor may account for 'trigger' differences in CC gene profiles. Collectively, these studies indicate that both the type of gonadotropin stimulus and 'trigger' should be taken into account when interpreting biomarker data. Patient age affects differential mRNA gene expression in CC and MGC (Hurwitz et al. 2010 , Lee et al. 2010 , McReynolds et al. 2012 , Al-Edani et al. 2014 , Kedem et al. 2014 as well as oocytes (Grondahl et al. 2010) . Patient BMI alters CC gene expression in both polycystic ovarian syndrome (PCOS) (Kenigsberg et al. 2009 ) and non-PCOS women (Robker et al. 2009 ). Therefore, studies with a large range of ages or BMIs may show DRGE profiles that would not exist if the age ranges or BMI were controlled for in the studies.
An individual patient's diagnosis may also influence DRGE in CC and MGC. PCOS compared to non-PCOS (Catteau-Jonard et al. 2008 , Wei et al. 2012 , Meng et al. 2013 , Schmidt et al. 2014 , Lan et al. 2015 , endometriosis compared to non-endometriosis , Allegra et al. 2014 , Barcelos et al. 2015 and diminished ovarian reserve compared to normal ovarian reserve (Greenseid et al. 2011 , Jindal et al. 2012 , May-Panloup et al. 2012 ) have all been shown to alter gene expression. In fact, PCOS patients with or without insulin resistance were shown to have DRGE compared to non-PCOS normal control patients (Kaur et al. 2012) . Other pathologies may also alter gene expression but have not been examined. Including any of these diagnoses in studies may also alter the actual transcriptional profiles and should be avoided if possible or analyzed separately.
Another important factor to consider when evaluating DRGE in transcriptomic studies in whether or not mature and immature oocyte granulosa cells have been mixed together. Mature and immature oocyte CCs have differing mRNA expression patterns (Assou et al. 2006 , Gasca et al. 2007 , Kwon et al. 2010 , Ouandaogo et al. 2011 , Devjak et al. 2012 , Huang et al. 2013 , Grondahl et al. 2013 . In some cases, visually mature oocytes may exhibit immature gene expression profiles. If the mature oocyte granulosa gene expression pattern can be linked to live birth, the embryos resulting from those oocytes can be preferentially selected for uterine transfer.
Microarray and qRT-PCR studies in IVF populations in relation to embryo development and pregnancy
At this time, there is no one single gene transcript that appears to be capable of predicting which embryos produced by IVF will implant and lead to a live birth. The granulosa gene biomarker studies undertaken have varied among the chosen endpoints that include oocyte nuclear maturation, fertilization, day 2 and day 3 embryo morphologies, day 5 and day 6 blastocyst morphologies, implantation, ongoing pregnancy and live birth. Tables 1, 2 and 3 summarize the findings of studies that show genes positively associated with pregnancy or live birth ( Table 1 ), genes that have conflicting findings between different studies ( Table 2 ) and genes that data do not support an association with pregnancy or live birth (Table 3) . Although the most desirable endpoint for transcriptomics studies is live birth, several studies examined the gene expression of CC in relation to embryo development (McKenzie et al. 2004 , Hasegawa et al. 2005 , Zhang et al. 2005 , Cillo et al. 2007 , Feuerstein et al. 2007 , Anderson et al. 2009 , Assou et al. 2013 . As embryos with the best morphological appearance are usually selected for uterine transfer and have been shown to implant at a higher rate than morphologically low-quality embryos (van Loendersloot et al. 2010) , the gene expression profiles of these studies may serve as an indirect marker of embryo viability and be at least loosely related to live birth rates.
The first retrospective study to look at CC mRNA transcripts and pregnancy as the end point was conducted by Assou and coworkers (2008) . Thirty patients aged less than 35 years with MFI and with one or two day 3 embryos transferred were included in the study. The stimulation protocols were varied and included GnRH agonist or antagonist with rFSH or hMG. The data showed that there was at least 2-fold DRGE between the pregnant and not pregnant groups. Out of the 569 upregulated genes in the pregnant group, pathway analysis showed enrichment in genes associated with oxidative stress and nuclear factor kappa-light-chain-enhancer of activated B cells (NFKB) signaling. Of the 61 downregulated genes associated with pregnancy, pathways included IGF1 and Sonic hedgehog signaling. Five CC masses each from pregnant patients and non-pregnant patients were used to further validate the microarray data. BCL2 like 11 (BCL2L11) and phosphoenolpyruvate carboxykinase 1 (PCK1) were downregulated, whereas nuclear factor I B (NFIB) was upregulated in pregnant vs non-pregnant samples. There was no analysis performed for the mixed stimulation protocols, and thus, it is difficult to determine the influence of stimulation type. The qRT-PCR analyses were only performed on 5 samples each, which limits the statistical power. The upregulation of nearly 600 genes in the pregnant group may indicate that the genome of CC may need to become transcriptionally activated to produce an oocyte and embryo capable of achieving pregnancy. As a follow-up to their 2008 study, Assou and coworkers (2010) identified 45 genes as CC biomarkers associated with pregnancy. They conducted a prospective study with patients <36 years old undergoing IVF with intra-cytoplasmic sperm injection (ICSI). The study was split into two groups where the two day 3 embryos selected for transfer were chosen either based on the CC mRNA expression profile or embryo morphology. In the first group, 267 individual CC from 30 patients were analyzed by qRT-PCR. Ongoing pregnancy rates per retrieval were 70% in the group that used qRT-PCR vs 47% for the morphology group alone demonstrating the use of CC mRNA expression as a useful prognostic tool. The authors note that a large cohort study would be the best way to confirm this data. Unfortunately, the genes examined in this study were not specified.
A similar study was the first to look at the CC gene expression transcriptome based on single embryo transfer (SET) (Hamel et al. 2008) . Forty women undergoing IVF with tubal factor, endometriosis or idiopathic infertility were part of the study. MGC and CC were pooled into 2 groups, those that formed a positive pregnancy and embryos that arrested. From these samples, CCs were used to construct a subtracted library and a custom-made granulosa array. After microarray analyses, 18 candidate genes with log 2 ratios >2 were validated by qRT-PCR with the pooled MGC samples. Five genes showed DRGE in the positive vs negative pregnancy groups with CYP19A1, cell division cycle 42 (CDC42), serpin family E member 2 (SERPINE2), hydroxy-delta-5-steroid dehydrogenase, 3 beta-and steroid delta-isomerase 1 (HSD3B) and ferredoxin 1 (FDX1) showing a statistically significant increase in the positive pregnancy groups. Drawbacks of the study are that the methods did not list the type of stimulation protocols used, endometriosis and idiopathic infertility patients were included, the numbers of patients with each diagnosis were not given and the different diagnoses were not considered in the data analyses. In a follow-up study, the MGC of transferred embryos from 18 patients were pooled from embryos that formed an ongoing pregnancy at 6-8 weeks or embryos that failed to implant (Hamel et al. 2010b) . Either one or two embryos were transferred on day 3 or 5. The patient population was mixed with tubal factor, idiopathic infertility and endometriosis, and the stimulation was not specified. Microarray analysis showed DRGE with log 2 ratios >2 preferentially expressed for 25 genes in the pregnancy group and 19 genes in the non-pregnant group. Validation of 10 genes was performed using qRT-PCR and showed UDP-glucose pyrophosphorylase 2 (UGP2) and pleckstrin homology-like domain family A member 1 (PHLDA1) gene expression was significantly higher in the pregnant group. In addition, the same lab performed a slightly different study and performed logistical regression analysis to determine which genes would best predict pregnancy (Hamel et al. 2010a) . Included in these analyses were 9 patients for intrapatient analysis with successful pregnancies vs arrested embryos, and 38 patients for inter-patient analysis that included a third group with unsuccessful pregnancies. One or two embryos were transferred on either day 3 or day 5. Successful pregnancies were defined as when either the single transferred or one or both of the two transferred embryos implanted. With two transferred embryos resulting in a singleton pregnancy, determining which embryo got implanted is difficult, so the study employed principal component analysis (PCA) to predict which embryo most likely implanted. PCA is a statistical method whereby the correlated variables from the embryos known to implant were used to estimate which one of a pair of embryos implanted when two were transferred but only one implanted. Phosphoglycerate kinase 1 (PGK1) and regulator of G protein signaling 2 (RGS2) were determined to be the best predictors of pregnancy from the intra-patient analysis, and PGK1 and CDC42 were the best predictors of pregnancy from the inter-patient analysis. Two separate studies combined traditional embryo morphology and zona pellucida birefringence (refractive index) to examine gene expression (Assidi et al. 2011 (Assidi et al. , 2015 . In the first study, CCs from 8 patients having the same stimulation protocol were divided into two groups based on positive or negative pregnancy results. Two day 3 post-insemination embryos for transfer per patient were selected based on good embryo morphology and high zona pellucida birefringence. Dipeptidyl peptidase 8 (DPP8), histone cluster 1 H4 family member c (HIST1H4C), ubiquilin 1 (UBQLN1), calmodulin 1 (CALM1), neuropilin 1 (NRP1) and proteasome 26S subunit, non-ATPase 6 (PSMD6) mRNA levels were all shown to be related to a positive pregnancy, whereas target of myb1 membrane trafficking protein (TOM1) was related to a negative pregnancy after embryo transfer. In the second study, seven patients with MFI were stimulated with GnRH agonist with hMG/FSH. Two day 3 embryos per patient were divided into CC with high zona pellucida birefringence and positive pregnancy and CC with low zona pellucida birefringence and negative pregnancy and compared. By microarray analysis, 48 genes were overexpressed and 27 genes were underexpressed by at least 2-fold. These genes included CALM1, NRP1 and PSMD6 as seen in the previous study. DPP8 and UBQLN1, as well as the 3 genes listed previously showed DRGE by qRT-PCR between the two groups; however, no correlation was seen between oocyte competence and zona pellucida birefringence, *Positive correlation with birth weight; **overexpressed in chromosomally normal oocytes. CC, cumulus cells; ea, each group; ICSI, intra-cytoplasmic sperm injection; MGC, mural granulosa cells; ns, not significant; preg, pregnant; pts, patients; SET, single embryo transfer. Symbols: > greater than; = equivalent to; < less than. 
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Reproduction (2017) 153 R69-R83 www.reproduction-online.org thereby indicating DRGE is a viable option for embryo selection, whereas refractive index may not be. Prostaglandin-endoperoxide synthase 2 (PTGS2) and VCAN mRNA expression were shown to be significantly higher in CC from oocytes that led to a live birth, and GREM1 and phosphofructokinase, platelet (PFKP) mRNA expression was correlated with the baby's birth weight (Gebhardt et al. 2011) . These results came from a retrospective study evaluating pregnancy resulting from 38 SETs, and all patients had long downregulation protocols with rFSH. Feuerstein and coworkers (2012) performed 96 microarray hybridizations and qRT-PCR with 197 individual CC masses from oocytes of 106 IVF patients and evaluated DRGE with oocyte maturity, blastocyst development and pregnancy. DRGE of ≥1.6-fold in CC was evaluated with pregnancy status in a subset of patients after day 5/6 blastocyst SET. RGS2 was shown to be linked to pregnancy potential, whereas pentraxin 3 (PTX3) showed a significant correlation with blastocyst development but only showed a positive correlation with pregnancy. Perilipin 2 (PLIN2) and angiogenin (ANG) were also associated with developmental competence. Papamentzelopoulou and coworkers (2012b) showed that a more robust CC LHCGR mRNA expression was positively associated with pregnancy. Forty patients undergoing GnRH agonist protocols with rFSH treatment and three day 3 embryo transfers were examined. Medium-to-high LHCGR expression was exhibited in 6 out of 7 patients who became pregnant. Runtrelated transcription factor 2 (RUNX2) gene expression, which is induced by the pre-ovulatory LH surge, was examined in CC (Papamentzelopoulou et al. 2012a ). This study examined 41 ICSI patients aged between 24 and 45 years being treated for MFI and each had at least one prior unsuccessful IVF cycle. All the patients were treated with a GnRH agonist protocol and had three day 3 embryos transferred. The RUNX2 gene was detected in 12 out of 41 women. Of the 12 expressing RUNX2 in the cumulus mass only 1 became pregnant, whereas 7 of the remaining 28 patients who did not express the gene did become pregnant. The presence of RUNX2 in CC may signify an oocyte that will likely not yield a pregnancy, whereas the presence of LHCGR mRNA could indicate embryos capable of forming a pregnancy. The combined use of both biomarkers, high LHCGR and low RUNX2, could be potentially useful for embryo selection.
Increased levels of GDF9 and BMP15 expression have both been associated with positive pregnancy as well as mature oocytes, fertilization rate and embryo quality (Li et al. 2014) . This study utilized one of the largest samples sizes to date, using 2426 CC masses from 196 patients with MFI, normal BMI, age 27-37 years and stimulated with a GnRH protocols with a 1-3 embryo transfer on day 3. GDF9 and BMP15 expression was analyzed by qRT-PCR. Considering that downstream genes affected by GDF9 and BMP15 such as PTGS2 and GREM1 have been shown to be related to pregnancy, it is not surprising that their own gene expression would serve as potential biomarkers for IVF success.
Although several studies have shown DRGE between the CC of embryos that form viable pregnancy and those that do not, several studies have also shown no significant DRGE between the groups. For example, Anderson and coworkers (2009) examined the genes hyaluronan synthase 2 (HAS2), brain-derived neurotrophic factor (BDNF), GREM1, PTGS2, tumor necrosis factor alphainduced protein 6 (TNFAIP6) and PTX3 and showed no correlation between the gene expression and pregnancy. Only GREM1 showed a higher gene expression trend with pregnancy, but it was not statistically significant. In this set of experiments, one or two day 2, 3 or 5 embryos were transferred. In two recent studies, evaluating CC and MGC gene profiles and implantation potential or fertilization, no gene differences were found to be significantly associated with these endpoints for day 5 SETs (Burnik et al. 2015a,c) . The authors selected 3 genes from the published literature that were proposed biomarkers in CC for pregnancy in at least 2 studies and were validated with qRT-PCR. RGS2 and VCAN showed no DRGE between CC of embryos that formed a pregnancy or did not, whereas ephrin B2 (EFNB2) showed a trend toward higher expression in the embryos that failed to form a pregnancy. In contrast to a previous granulosa cell study where an unspecified number of day 2 embryos were transferred (Fujino et al. 2008) , CC expression of survival factor gene BIRC5 showed no correlation with pregnancy when examined in Greek women who had 3 embryos transferred on day 2 or 3 (Varras et al. 2012) . Disagreement among studies regarding regulation of the same gene targets may be due to the more restrictive inclusion criteria in studies with negative findings such as exclusion of patients with particular diagnoses such as endometriosis or sample size differences.
In an effort to better identify abnormal embryos, Fragouli and coworkers (2012) used first polar bodies to access oocyte ploidy. DRGE (≥2-fold) between euploid and aneuploid oocytes was evaluated in CC. Women (n = 28) ranging in age from 23 to 46 with varied ovarian stimulation protocols that included GnRH agonist started in the mid-luteal phase of the previous cycle with rFSH, a combination of either GnRH agonist or an antagonist with rFSH, with or without hMG participated in the study. One or two embryos were transferred on day 3 or 5. Customized TaqMan low-density arrays (TLDAs) were utilized to evaluate CC transcriptomes and initially showed 729 potentially altered genes in CC associated with aneuploid oocytes. SplA/ryanodine receptor domain and SOCS box containing 2 (SPSB2) and putative quinone oxidoreductase (TP5313) were significantly downregulated in CC of aneuploid oocytes. SPSB2 showed a positive but non-significant correlation with live birth. If oocytes that lead to aneuploid embryos could be identified using CC gene profiles, it would be a valuable asset to the embryologist. The combined use of embryo morphological endpoints and chromosomal status data with granulosa cell gene expression profiles may lead to more precise prediction models.
Predictive models
All the previously discussed studies have examined the transcriptomes of CC or MGC based on the various endpoints of interest. However, none of the studies attempted to generate a predictive model for prospective embryo selection based upon the gene expression profiles until Wathlet and coworkers (2011) . This study examined 25 patients stimulated with GnRH antagonist with rFSH and compared them to 20 patients stimulated with GnRH agonist with HP-hMG who had one or two embryos transferred on day 3 or 5. The causes of infertility were mixed with 10% idiopathic, 55% male factor only, 19% combined male and female (3% PCOS, tubal 6% and endometriosis 10%), and 16% endometriosis. Multivariable stepwise regression analysis was performed to develop several predictive models of embryo competence and pregnancy. Better day 3 embryo quality prediction models included transient receptor potential cation channel subfamily M member 7 (TRPM7) and inositol-trisphosphate 3-kinase A (ITPKA), whereas pregnancy prediction models included VCAN and SDC4. The best pregnancy prediction model had a sensitivity of 74% and a specificity of 91%. It is worth noting that the strongest prediction models not only included the CC gene transcription profiles but also included other parameters such as the number of COC retrieved/gonadotropin dose and day 3 embryo cell number. Wathlet and coworkers (2012) performed a follow-up study using a different gene set. In this study, 11 genes in 99 CC masses from 33 patients were examined with SET on day 3 or 5. The patient population was again mixed with 55% male factor only, 9% female factor (endometriosis, ovulation disorder and myomatosis), male and female factor 12% (tubal and PCOS) and 24% idiopathic infertility. All patients were stimulated with GnRH antagonist protocols with rFSH (Gonal-f or Puregon). For all pregnancy and live birth analyses, only the transferred oocytes were considered. The best live birth prediction model with gene expression utilized calcium/calmodulindependent protein kinase ID (CAMK1D), EFNB2 and stanniocalcin 2 (STC2). The full predictive model for live birth contained the same genes as well as the days of stimulation. Although VCAN was again assessed in this study, its gene expression did not differ between the pregnant and non-pregnant patients. This may be due to the fact that the patient infertility diagnoses differed between the two studies with respect to the proportion of each type of infertility as PCOS and endometriosis have both been shown to alter the transcriptome as mentioned previously.
Building upon the two previous studies, a third study was conducted validating the CAMK1D, EFNB2 and STC2 model and evaluating 9 additional candidate genes (Wathlet et al. 2013) . Also for the first time, an intra-patient model in relation to frozen/thawed embryos from the same patient was examined. CC from 47 patients undergoing SET with day 3 or 5 embryos and stimulated with GnRH antagonist protocols were analyzed. Using just CAMK1D, EFNB2, and STC2 in the model, an accuracy of 72% was obtained. Five of the 12 genes gave the best predictive model and included EFNB2, glutathione peroxidase 3 (GPX3), glutathione S-transferase alpha 3 (GSTA3), glutathione S-transferase alpha 4 (GSTA4), and progesterone receptor (PGR). The model gave a positive predictive value of 78%, a negative predictive value of 83% and an accuracy of 81%. Adding the days of stimulation, relative serum estradiol and age to the model increased all three model endpoints to 93%. The receiver-operating characteristic (ROC) curves for the two models were 0.93 and 0.95. For intra-patient pregnancy prediction, the 5 gene predictive model was used as the patient characteristics were the same in each patient. The model was able to correctly rank the embryos in 6 of 7 patients. These three studies taken together represent, as the authors state, a 'cascade' strategy for selecting candidate genes. The genes yielding the best predictive model from one set of candidate genes are kept and the ones that do not show any predictive value are discarded, and then a new set of genes are tested along with the predictive set and kept or discarded in the same way to yield the best model. Iager and coworkers (2013) conducted a retrospective study between 3 different clinical sites to compare a pregnancy prediction model accounting for patient and clinical variation. The endpoints for this study were pregnancy and live birth from 1 to 3 embryos transferred on days 2, 3 or 5. Although most studies of microarray gene expression choose genes with 1.5-or 2.0-fold changes to pursue further, these authors used a different methodology to select their candidate genes. A training gene set revealed 1180 differentially expressed genes that were narrowed down to 227 in the validation set using weighted voting analysis. From the 227 predictive genes, a custom TLDA using 196 of these was made. This TLDA array was used to further narrow the predictive gene set down using a modified Fisher test with α = 0.01 to determine significance. Collectively, 12 genes were statistically significant with their individual fold changes ranging between −6.52-and 1.57-fold. These included fibroblast growth factor 12 (FGF12), G proteincoupled receptor 137B (GPR137B), solute carrier family 2 member 9 (SLC2A9), AT-rich interaction domain 1B (ARID1B), nuclear receptor subfamily 2 group F member 6 (NR2F6), zinc finger protein 132 (ZNF132), COX20, cytochrome c oxidase assembly factor R80 Ekart and coworkers (2013) developed a ranking system for selection of mature oocytes that would theoretically lead to pregnancy based on CC gene transcription. In this retrospective study, they selected an 8 gene panel, HAS2, follicle=stimulating hormone receptor (FSHR), solute carrier family 2 member 4 (SLC2A4), activated leukocyte cell adhesion molecule (ALCAM), secreted frizzled-related protein 2 (SFRP2), VCAN, NRP1 and PGR based on prior published studies (McKenzie et al. 2004 , Gebhardt et al. 2011 , Wathlet et al. 2011 , Fragouli et al. 2012 , Iager et al. 2013 to predict the mature oocytes that would lead to live birth. Based on their qRT-PCR results, it was determined that HAS2, FSHR, VCAN and PGR would be the best genes to rank the oocytes. If embryos had been chosen based on the model from the four gene transcript levels, a single good blastocyst for transfer on day 5 or 6 capable of implantation would have been selected 76% of the time. As the authors acknowledge, the method needs to be validated in a large unselected population to assess its validity on a larger scale. This implies that an embryologist could choose which oocytes to inseminate based on the gene expression of the CC.
Recently, the difference in MGC and CC transcriptomes were analyzed to develop a statistical classification system using a support vector machine algorithm to predict live birth (Borup et al. 2016) . Samples were collected from 60 women stimulated with long GnRH agonist protocols with SET on day 3. Sixteen individual CCs and their paired MGCs that were associated with a live birth and 16 age-and embryo morphology-matched CCs and their paired MGCs that failed to form a pregnancy were analyzed. In total, 30 genes found in CC were predictive of live birth with an accuracy of 81%, a positive predictive value of 77%, a negative predictive value of 86% and a ROC curve of 0.86. This model was further applied to three other data sets using blastocyst formation as the end point and had a prediction accuracy of 62%, 75% and 88% respectively. The genes included in the model were related to apoptosis and extracellular matrix formation.
These above studies show that the use of several genes can generate predictive models with good accuracy and ROC curves. It is also apparent that the models are incomplete and need further testing. The addition of patient characteristics to the models seems to improve the specificity as well. None of these models, with the exception of the Iager and coworkers' (2013) study, have been validated by an outside group to confirm the accuracy of the models across different labs.
Conclusions and future directions
CC and MGC associated with individual oocytes may be a valuable source for identifying biomarkers that result reliably in choosing embryos capable of leading to a live birth. Table 1 also suggests that biomarkers associated pregnancy and live birth are more commonly found in CC than MGC, which might be expected since the CC have direct contact with the oocyte at the time of retrieval. From the reviewed studies, it is apparent that identification of a single expressed gene to predict pregnancy is highly unlikely and that a model with multiple genes and cycle characteristics may yield the best results. With the numerous possible confounding factors including differing IVF stimulation protocols, diagnoses, age, BMI and other factors careful patient selection is essential in identifying granulosa cell biomarkers for models to predict live birth. Additionally, it is important to note that the paternal contributions to embryo quality in the above studies have not been assessed, and this is another variable for live birth outcomes. With the many differing characteristics of IVF patients to consider when looking for potential biomarkers, stepwise multivariate analysis may be the most promising approach for selecting embryos for uterine transfer. With this type of analysis, the main measured endpoints are written as a function of the DRGEs of the most predictive genes which can be corrected for variations based on patient demographics and cycle variations (Adriaenssens et al. 2010) . The ability to create and test these types of predictive models will allow clinicians across multiple sites to fine tune identified biomarkers and perhaps revolutionize the way embryos are selected from uterine transfer and increase IVF success rates.
Although many studies have focused on outcomes derived from inseminating mature oocytes, there is no guarantee that the embryos evaluated were genetically normal at the time of uterine transfer. Combining granulosa cell transcriptomics and PGS may be a next step in improving embryo selection for uterine transfer, as this would allow correlation of embryo ploidy status and gene expression biomarkers of CC and/or MGC with live birth. Granulosa biomarkers may have additional applications as well. During oocyte retrieval, a variety of oocytes at different stages of maturity are recovered. Given that many mature oocytes are morphologically similar, granulosa cell biomarkers may be useful in identifying a mature oocyte that is prior to or past the optimal window of insemination. It is conceivable that in the future MGC and CC biomarkers may be assessed prior to oocyte insemination and only those oocytes capable of resulting in a live birth will be inseminated.
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